CCL2 and type 2 diabetes mellitus: Increased levels of inflammatory mediators including soluble intercellular adhesion molecule 1, vascular endothelial growth factor 1, monocyte chemotactic protein 1, and interleukin 6 were observed in both T2DM and RVO patients (43–46).